CARsgen Therapeutics Holdings Limited (2171)の価格はいくらですか

CARsgen Therapeutics Holdings Limited (2171)の価格は$1.72です

CARsgen Therapeutics Holdings Limited (2171)の時価総額は何ですか

CARsgen Therapeutics Holdings Limited (2171)の時価総額は$981.92Mです

CARsgen Therapeutics Holdings Limited（2171）の株価履歴

CARsgen Therapeutics Holdings Limited, a biopharmaceutical firm founded in Shanghai, China, in 2014, focuses on the discovery, development, and commercialization of advanced chimeric antigen receptor T (CAR-T) cell therapies. The company's efforts are directed toward treating various hematological malignancies and solid tumors across China and the United States. Its robust pipeline includes several key candidates: CT053, an autologous CAR-T product, is currently in a pivotal Phase II trial in China for relapsed/refractory multiple myeloma. Additionally, CT041, another autologous CAR-T, is undergoing Phase Ib/II clinical trials for advanced gastric/gastroesophageal junction and pancreatic cancers in China, and Phase Ib trials for comparable indications in the U.S. CARsgen is also advancing CT011, an autologous CAR-T candidate, through Phase I for patients with Glypican-3 positive advanced hepatocellular carcinoma, and CT032, an autologous CAR-T, in Phase I/II for B cell Non-Hodgkin's lymphoma in China. Furthermore, its pipeline features AB011, a humanized monoclonal antibody in Phase I for CLDN18.2 positive solid tumors in China, as well as CT017, an autologous Glypican-3-targeted CAR-T for hepatocellular carcinoma, and other promising therapies for solid tumors.

年	パフォーマンス
2026 (TTM)	6.63%
2025	89.86%
2024	11.34%
2023	-48.93%
2022	-58.99%
2021	0.00%

年

パフォーマンス

2026 (TTM)

6.63%

2025

89.86%

2024

11.34%

2023

-48.93%

2022

-58.99%

2021

0.00%

企業	株価	変化率 1年%	国
Vertex Pharmaceuticals Incorporated VRTX.US	$542.09	38.63%	US
Argenx SE ARGX.US	$1.03K	44.13%	NL
CSL Limited CSL.AX	$121.53	-12.70%	AU
Moderna, Inc. MRNA.US	$138.18	473.58%	US
Lonza Group AG LONN.SW	$759.27	7.20%	CH

企業

株価

変化率 1年%

国